Cyp3a Inducers + Capmatinib Interaction

Majorinteraction on record

Description

Coadministration with strong CYP3A inducers decreased capmatinib exposure, which may decrease TABRECTA anti-tumor activity. Avoid coadministration.

Mechanism

CYP3A induction decreases capmatinib exposure

Source: NLP:capmatinib

Related drug profiles

All Cyp3a Inducers interactions →All Capmatinib interactions →
Share this page:XFacebookWhatsAppReddit